CardieX Ltd.

CardieX Ltd.

CardieX Ltd.

Overview
Date Founded

2005

Headquarters

15 Lime Street,Suite 303, Level 3,Sydney, New South Wales (NSW) 2000

Type of Company

Public

Employees (Worldwide)

27

Industries

Medical Products & Equipment
Hospitals & Patient Services

Company Description

CardieX Ltd. engages in the design, manufacture, and marketing of medical devices which is used for cardiovascular management. It operates through the following geographical segments: Americas, Europe, and Asia Pacific. The Americas segment is comprised of global pharmaceutical trials business. The Europe segment consist of Middle East and Africa. The Asia Pacific segment involves Asia, Australia, and New Zealand. The company was founded by Ross Harricks and Michael O'Rourke in 1993 and is headquartered in Sydney, Australia.

Contact Data
Trying to get in touch with decision makers at CardieX Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer, MD & Executive Director

Chief Financial Officer & Secretary

General Manager & Head-Global Sales

Global Head-Marketing & Communications

Chief Financial Officer, Managing Director & Non-Executive Director

Director-Corporate Development

Director-Product & Technology Development

Principal Scientist

Vice President, Operations

Joint Secretary

Board of Directors

Fund Advisor at SCP Management LLC - New York

Chief Executive Officer at Q'Apel Medical LLC

Paths to CardieX Ltd.
Potential Connections via
Relationship Science
You
CardieX Ltd.
Recent Transactions
Details Hidden

CardieX Ltd. issued AUD Ordinary Shares

Transaction Advisors
Underwriter

Advised onCardieX Ltd. issued AUD Ordinary Shares

Auditor

Advised onCardieX Ltd. issued AUD Ordinary Shares

Clients

GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals, Vaccines, Consumer Healthcare, and Corporate Executive Team (CET). The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The CET segment refers to the management of business activities. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

The Mayo Clinic is a nonprofit academic medical center based in Rochester, Minnesota, focused on integrated clinical practice, education, and research. It employs more than 4,500 physicians and scientists and 58,400 administrative and allied health staff. The practice specializes in treating difficult cases through tertiary care. It spends over $660 million a year on research and employs over 3,000 full-time research personnel.

NYU Langone Medical Center, a world-class, patient-centered, integrated, academic medical center, is one of the nation’s premier centers for excellence in clinical care, biomedical research and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals: Tisch Hospital, its flagship acute care facility; the Hospital for Joint Diseases, one of only five hospitals in the nation dedicated to orthopaedics and rheumatology; Hassenfeld Pediatric Center, a comprehensive pediatric hospital supporting a full array of children’s health services; and the Rusk Institute of Rehabilitation Medicine, the world’s first university-affiliated facility devoted entirely to rehabilitation medicine--plus NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The medical center’s tri-fold mission to serve, teach and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education and research.

Key Stats and Financials As of 2019
Market Capitalization
$19.6M
Total Enterprise Value
$15.4M
Earnings Per Share
$0
Revenue
$3.91M
EBITDAMargin
-99.89%
Enterprise Value Sales
3.93x
TEVNet Income
-5.15x
Debt TEV
0.3x
Net Profit
$-2.98M
Total Equity
$6.95M
Total Debt
$4.53M
EBITDA
$-3.9M
Three Year Compounded Annual Growth Rate Of Revenue
-8.01%
Five Year Compounded Annual Growth Rate Of Revenue
-5.01%
Investments
Details Hidden

Blumio, Inc. develops wearable sensors to continuously monitor blood pressure without needing to squeeze the arm. The company was founded by Catherine Liao, Lillian Dai, and Oliver Shay on October 15, 2012 and is headquartered in Miami Beach, FL.

Suppliers
Halma Plc Industrial Machinery & Manufacturing | Amersham, United Kingdom

Halma Plc is a holding company which engages in the development, production and sale of hazard and life protection products. It operates through the following segments: Process Safety, Infrastructure Safety, Medical, and Environmental and Analysis. The Process Safety segment offers products to protect people and assets at work such as interlocks that control critical processes safely; instruments that detect flammable and hazardous gases; explosion protection and pressure relief systems, and corrosion monitoring products. The Infrastructure Safety segment offers life protection in infrastructure and for save movement such as fire detection systems, smoke detectors, fire suppression, people and vehicle flow solutions, security solutions, and elevator safety products. The Medical segment specializes in devices that assess eye health, assist with eye surgery and primary care applications, critical fluidic components used by medical diagnostic original equipment manufacturers, and laboratories; sensor technologies used in hospitals to track assets and support patient and staff safety. The Environmental and Analysis segment relates to products and technologies for analysis in environmental safety and life sciences markets such as opto-electronic technology and sensors. The company was founded in 1894 and is headquartered in Amersham, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by CardieX Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of CardieX Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and CardieX Ltd..